Search results for "PPAR"

showing 10 items of 1686 documents

Intravitreal Pegaptanib in Ischemic CRVO Refractory Exudative Macular Detachment

2012

Abstract Recent literature data reported evidence of the visual and/or anatomical benefits of all clinically available anti-VEGF drugs for the treatment of macular edema (ME) following Central Retinal Vein Occlusion (CRVO), up to 1-year followup. There are no randomized clinical trial data on anti-VEGF agents in ischemic CRVO-ME and the use of anti-VEGF agents to treat this condition. A 73-year old caucasian man, with a medical history of diabetes and systemic hypertension and an ophthalmic history of ischemic CRVO with cystoid macular edema was referred to our division on January 2011. The ophthalmic examination showed in right eye a visual acuity of 20/2000, a C2N1 cataract and an exudati…

medicine.medical_specialtyVisual acuitygenetic structuresPegaptanibIntravitreal pegaptanibCentral retinal vein occlusionOphthalmologymedicinePegaptanib SodiumExudative macular detachment; Central retinal vein occlusion; Intravitreal pegaptanibMedical historyMacular edemamedicine.diagnostic_testSettore MED/30 - Malattie Apparato Visivobusiness.industryCentral retinal vein occlusionExudative macular detachmentmedicine.diseaseFluorescein angiographyeye diseasesSurgerysense organsmedicine.symptomRanibizumabbusinessmedicine.drugJournal of Clinical & Experimental Ophthalmology
researchProduct

Direct Oral Anticoagulants in the Setting of Catheter Ablation of Atrial Fibrillation: State of art

2021

Atrial fibrillation (AF) represents the arrhythmia of greatest clinical impact and catheter ablation of AF (CAAF) has become the most effective strategy for rhythm control in selected patients. Therefore, appropriate anticoagulation strategies are of paramount importance for patients undergoing CAAF, especially those at high risk, such those with high CHA2DS2VASc scores. Optimal management of anticoagulation before, during, and after CAAF is crucial. Several studies have evaluated the use of different anticoagulation strategies in the periprocedural period. Randomized controlled trial seem to suggest that in patients undergoing CAAF, uninterrupted (or minimally interrupted) direct oral anti…

medicine.medical_specialtyVitamin Kmedicine.medical_treatmentAdministration OralRhythm controlCatheter ablation030204 cardiovascular system & hematologyVitamin klaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineVitamin K/administration & dosagecatheter ablationmedicineHumansrisk factorsIn patientatrial fibrillation030212 general & internal medicineanticoagulationRandomized Controlled Trials as TopicAnticoagulants/administration & dosagebusiness.industryAnticoagulantsAtrial fibrillationGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareOptimal managementTreatment OutcomeState of artCardiologybusinessCardiology and Cardiovascular MedicineAtrial Fibrillation/complications
researchProduct

Rötliche Lidschwellung nach Dakryozystographie

2000

medicine.medical_specialtybusiness.industryEye diseasePerforation (oil well)Lacrimal apparatusmedicine.diseaseExtravasationSurgeryOphthalmologymedicine.anatomical_structureText miningmedicineComplicationbusinessDer Ophthalmologe
researchProduct

Beneficial Effects of CPAP Treatment in High-risk Subgroups of OSA Patients: Some Evidence, at Last.

2018

the clinical and pathophysiological links between obstructive sleep apnea (OSA) and cardiovascular

medicine.medical_specialtybusiness.industryGeneral Medicine030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciences0302 clinical medicineText mining030228 respiratory systemChest diseseCommentarymedicineCpap treatmentIntensive care medicinebusinessBeneficial effectsEClinicalMedicine
researchProduct

Cardiovascular consequences of sleep disordered breathing: the role of CPAP treatment

2020

CPAP treatment decreases BP in OSA patients, especially in severe OSA, and in patients with poorly controlled BP. OSA adversely affects heart function and remodelling, but its role in the pathogenesis of HF remains unclear. Similarly, the impact of CPAP is uncertain, and results of the ongoing ADVENT-HF trial will provide more information. Several experimental studies in animals and humans indicate a central role of intermittent hypoxia in atherogenesis through multiple mechanisms. However, randomised controlled trials (RCTs) in patients with CAD and OSA found no difference in outcomes between CPAP-treated and untreated patients. The negative results of secondary prevention RCTs may be the …

medicine.medical_specialtybusiness.industryInternal medicinerandomized controlled trialsSleep disordered breathingCardiologyblood pressureMedicineCpap treatmentSettore MED/10 - Malattie Dell'Apparato Respiratorioarrhythmiabusiness
researchProduct

Editorial commentary: Sleep disordered breathing and cardiovascular outcomes: is it time to change our thinking?

2017

no abstract

medicine.medical_specialtybusiness.industryPolysomnographySleep apnea030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaseCardiovascular Systemlaw.inventionSleep apnea Cardiovascular outcomes Randomized controlled trial03 medical and health sciences0302 clinical medicineSleep Apnea Syndromes030228 respiratory systemRandomized controlled triallawSleep disordered breathingPhysical therapyMedicineHumansCardiology and Cardiovascular MedicinebusinessIntensive care medicineCardiovascular outcomes
researchProduct

Inspiration through the nose increases the bronchoprotective effect of lung inflation

2007

medicine.medical_specialtybusiness.industryVital CapacityImmunologyBronchiNoseSettore MED/10 - Malattie Dell'Apparato Respiratoriodeep inspiration asthma lung functionmedicine.anatomical_structureInhalationForced Expiratory VolumeInternal medicineCardiologymedicineHumansImmunology and AllergyLung inflationbusinessLungNose
researchProduct

Asthma in the elderly

2010

Asthma is frequent among older people. Nevertheless, under-recognition, misdiagnosis and under-treatment are still relevant issues. We aim to provide an overview of epidemiology of asthma in the elderly, and a thorough description of its pathology and clinical presentation, with special emphasis on the distinction of late versus early-onset asthma. We also discuss selected treatment topics of special interest for older patients, such as compliance with therapy and ability with the inhalers, which are basic to the success of the prescribed therapy. Finally, we suggest that multidimensional geriatric assessment of older asthmatics could help in tailoring the therapy to the individual needs a…

medicine.medical_specialtybusiness.industrymedia_common.quotation_subjectGeriatric assessmentGeneral MedicineSettore MED/10 - Malattie Dell'Apparato RespiratorioSpecial Interest Groupmedicine.diseaseelderlyAsthmaCompliance (psychology)PresentationOlder patientsEpidemiologymedicineGeriatrics and GerontologyIntensive care medicineOlder peoplebusinessmedia_commonAsthmaAging Health
researchProduct

Mesh Plates for Scapula Fixation

2015

While scapula fractures are often treated nonoperatively, there are a number of displaced fractures in which surgical treatment can be considered. When necessary, open reduction and internal fixation with plates is the accepted method for stabilization. However, there are limited options of commercially available plates for fixation of the scapula. The authors describe 2 cases of scapula fracture and 1 scapula osteotomy that were managed with internal fixation using low-profile mesh plates. The mesh plate is a stainless steel lattice that can be molded and trimmed to create a plate that matches the unusual 3-dimensional anatomy of the scapula. It accepts 2.4/2.7 mm cortical and variable ang…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentSurgeryDisplaced fracturesFixation (surgical)scapula fracture mesh plateScapulaSettore MED/33 - Malattie Apparato LocomotoreMedicineInternal fixationSurgerybusinessSurgical treatment
researchProduct

Dietary strategy for prevention and management of dyslipidemia: international guidelines

2012

Primary prevention of cardiovascular disease should begin with a detailed metabolic study of our patients who must follow a nutritional therapy. Recently, new guidelines ESC/EAS 2011 on the treatment of dyslipidemia have been drawn up, according to which it is possible to arrive at desirable values of cholesterol and triglycerides with a synergy between drug treatment and adequate diet therapy. At this time, Mediterranean diet has been undergoing a radical transformation: there is hyperalimentation of the Mediterranean diet in all its components. The effectiveness of the Mediterranean diet on the reduction of lipids has been demonstrated, and the problem is how to implement this diet in the…

medicine.medical_specialtyeducation.field_of_studySettore MED/09 - Medicina InternaNutrition and DieteticsMediterranean dietCholesterolDiet therapybusiness.industryEndocrinology Diabetes and MetabolismPopulationDiseasemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolarechemistry.chemical_compoundchemistryDiabetes mellitusmedicinePhysical therapyMedical nutrition therapyIntensive care medicineeducationbusinessDyslipidemiaDietDyslipidemia Prevention Guidelines EducationFood ScienceMediterranean Journal of Nutrition and Metabolism
researchProduct